Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
HKEX:874

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
HKEX:874
Watchlist
Price: 18.6 HKD 0.16% Market Closed
Market Cap: 45.7B HKD

Profitability Summary

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's profitability score is 47/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

47/100
Profitability
Score
47/100
Profitability
Score

Margins

Earnings Waterfall
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Margins Comparison
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors

Country Company Market Cap Gross
Margin
Operating
Margin
Net
Margin
CN
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
41B CNY
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
977.5B USD
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.4B USD
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
272.5B CHF
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.5B GBP
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.3B CHF
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.7B USD
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
144.7B USD
Loading...
Loading...
Loading...
No Stocks Found

Return on Capital

Return on Capital Comparison
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitors

Country Company Market Cap ROE ROA ROCE ROIC
CN
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
41B CNY
Loading...
Loading...
Loading...
Loading...
US
Eli Lilly and Co
NYSE:LLY
977.5B USD
Loading...
Loading...
Loading...
Loading...
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP
Loading...
Loading...
Loading...
Loading...
US
Johnson & Johnson
NYSE:JNJ
519.4B USD
Loading...
Loading...
Loading...
Loading...
CH
Roche Holding AG
SIX:ROG
272.5B CHF
Loading...
Loading...
Loading...
Loading...
UK
AstraZeneca PLC
LSE:AZN
206.5B GBP
Loading...
Loading...
Loading...
Loading...
CH
Novartis AG
SIX:NOVN
219.3B CHF
Loading...
Loading...
Loading...
Loading...
US
Merck & Co Inc
NYSE:MRK
269.7B USD
Loading...
Loading...
Loading...
Loading...
DK
Novo Nordisk A/S
CSE:NOVO B
1.7T DKK
Loading...
Loading...
Loading...
Loading...
IE
Endo International PLC
LSE:0Y5F
218B USD
Loading...
Loading...
Loading...
Loading...
US
Pfizer Inc
NYSE:PFE
144.7B USD
Loading...
Loading...
Loading...
Loading...
No Stocks Found

Free Cash Flow

Free Cash Flow Analysis
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate